Status:

COMPLETED

Valacyclovir in Neonatal Herpes Simplex Virus Disease

Lead Sponsor:

University of Alabama at Birmingham

Conditions:

Neonatal Herpes Simplex Infection

Eligibility:

All Genders

2-12 years

Phase:

PHASE1

Brief Summary

This is an open-label, single center, pharmacokinetic (PK) study to assess valacyclovir pharmacokinetics and pharmacodynamics in neonates and compare to the pharmacokinetics and pharmacodynamics of th...

Detailed Description

This is an open-label, single center, PK study to assess valacyclovir pharmacokinetics and pharmacodynamics in neonates and compare to the pharmacokinetics and pharmacodynamics of the standard of care...

Eligibility Criteria

Inclusion

  • Signed informed consent from parent(s) or legal guardian(s)
  • Confirmation of HSV infection from surface culture/PCR, skin lesion culture/PCR, blood PCR, or CSF PCR (performed at UAB Virology lab)
  • ≥34 weeks gestational age at birth
  • Weight at study enrollment is ≥ 2000 grams
  • Receiving intravenous acyclovir, prescribed by the patient's physician for ≤ 14 days
  • ≤ 42 days of age at initiation of parenteral acyclovir
  • Creatinine ≤ 1.2

Exclusion

  • Imminent demise
  • Current receipt of other investigational drugs
  • Major congenital anomaly that in the site investigator's opinion may impact drug metabolism or the patient's volume of distribution
  • Creatinine of \> 1.2 prior to initiation of valacyclovir
  • Evidence of immunosuppression (HIV infected, immune deficiencies, etc.)
  • Any condition that, in the opinion of the investigator, would place the subject at an unacceptable injury risk or that may interfere with successful study completion
  • \> 42 days of age at initiation of parenteral acyclovir
  • Concern for parental/guardian compliance

Key Trial Info

Start Date :

July 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 24 2024

Estimated Enrollment :

7 Patients enrolled

Trial Details

Trial ID

NCT04448392

Start Date

July 1 2021

End Date

July 24 2024

Last Update

June 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Alabama - Children's of Alabama

Birmingham, Alabama, United States, 35233-1711

Valacyclovir in Neonatal Herpes Simplex Virus Disease | DecenTrialz